33.06.02 · history-of-science / genetics-molecular-bio

The double helix and molecular biology: Franklin, Watson-Crick, and the central dogma

stub3 tiersLean: nonepending prereqs

Anchor (Master): Watson, J. D. — The Double Helix (1968)

Intuition Beginner

The discovery of DNA's structure in 1953 ranks among the most important moments in the history of science. Within a single decade, biologists learned how heredity is stored, copied, and read — and within a half-century they could rewrite it. The story runs from a monk's pea garden to a machine that prints genomes, and it turns on a photograph taken by a woman who did not live to see what her image made possible.

Rosalind Franklin (1920–1958) was a chemist at King's College London who used X-ray crystallography to probe molecular structure. Her 1952 image, "Photograph 51," showed a distinctive cross-shaped pattern that only a helix could produce. From the geometry of the spots she could read the diameter of the molecule, the spacing of its repeating units, and the angle of its twist. The data were unambiguous: DNA is a helix, and its dimensions were now measured.

James Watson and Francis Crick, at Cambridge, used Franklin's measurements to build a physical model. Their double helix — two strands wound around each other, held together by complementary base pairs (adenine with thymine, guanine with cytosine) — was published in Nature on 25 April 1953. The model's power was not merely that it fit the data, but that it immediately explained how DNA replicates: the strands separate, and each serves as a template for a new partner.

Francis Crick later named the "central dogma": genetic information flows from DNA to RNA to protein, and never in reverse. The question then became how a four-letter alphabet specifies the twenty amino acids that build proteins. Marshall Nirenberg answered it in 1961: three-letter codons. Each triplet of bases names one amino acid, and the cell's machinery reads them off in sequence.

By the 1970s scientists had learned to cut DNA at specific sequences and join fragments from different organisms — recombinant DNA technology. Kary Mullis's polymerase chain reaction (1983) made it possible to copy a chosen DNA segment a billionfold. The Human Genome Project (1990–2003) read all three billion letters of human DNA, opening the era of genomic medicine.

Visual Beginner

Year Milestone Key figure(s) Significance
1865 Laws of inheritance Mendel Particulate heredity; ignored until 1900
1944 DNA is genetic material Avery, MacLeod, McCarty Heredity carried by DNA, not protein
1952 Photo 51 Franklin X-ray image revealing the helix
1952 Blender experiment Hershey, Chase Viral DNA, not protein, enters cells
1953 Double helix Watson, Crick Complementary base pairing; replication
1957–58 Central dogma Crick DNA → RNA → protein
1958 Semi-conservative replication Meselson, Stahl Each daughter keeps one parental strand
1961 Triplet code cracked Nirenberg, Matthaei UUU = phenylalanine
1970s Recombinant DNA Berg, Boyer, Cohen Cut and paste DNA; Asilomar 1975
1983 PCR Mullis Amplify specific DNA sequences
1990–2003 Human Genome Project International consortium All 3 billion base pairs sequenced

Worked example Beginner

A DNA strand is a chain of four bases, abbreviated A, T, G, C. The two strands of the double helix are complementary: wherever one has A, the other has T; wherever one has G, the other has C. This pairing rule (A↔T, G↔C) is the whole secret of heredity.

Consider a short segment of one DNA strand:

5'– A T G C C A G T A –3'

Its partner, built by the pairing rule, reads in the opposite direction:

3'– T A C G G T C A T –5'

When the gene is expressed, the coding information is first copied into messenger RNA (mRNA). In RNA the base U (uracil) replaces T:

mRNA: 5'– A U G C C A G U A –3'

The cell's ribosome reads this mRNA in non-overlapping triplets. Each triplet is a codon:

  • AUG → methionine (Met)
  • CCA → proline (Pro)
  • GUA → valine (Val)

The protein fragment is therefore Met–Pro–Val. A gene thousands of bases long produces a protein hundreds of amino acids long, read off three bases at a time. The beauty of the double helix is that all of this — replication, transcription, translation — follows from one simple rule: complementary base pairing.

Check your understanding Beginner

Formal definition Intermediate+

The molecular-biology revolution rests on four formal structures: the geometry of the double helix, the combinatorial logic of the genetic code, the diffraction physics that made the structure visible, and the directional information flow Crick called the central dogma. Each is stated below.

B-form DNA geometry. In its commonest form (B-DNA), the molecule consists of two antiparallel polynucleotide strands wound around a common axis to form a right-handed double helix. Each strand is a chain of nucleotides linked by phosphodiester bonds running 5' → 3'. The nitrogenous bases project inward and pair across the axis by hydrogen bonds: adenine (A) with thymine (T) via two hydrogen bonds, and guanine (G) with cytosine (C) via three. The idealized helical parameters are: diameter ≈ 2.0 nm (20 Å); rise per base pair ≈ 0.34 nm (3.4 Å); helical pitch ≈ 3.4 nm (34 Å); approximately 10 base pairs per turn (10.5 in solution). The rotation of the backbones exposes two grooves of unequal width — the major groove (2.2 nm) and the minor groove (1.2 nm) — through which regulatory proteins read the base sequence without prying the helix open.

Chargaff's rules. Erwin Chargaff showed in 1950 that in double-stranded DNA the molar fraction of adenine equals that of thymine (), and the molar fraction of guanine equals that of cytosine (). Equivalently, , and the ratio varies by species. These equalities are consequences of complementary base pairing: every A on one strand pairs with a T on the other, and every G pairs with a C. Chargaff's data were a decisive clue for Watson and Crick, confirming that the bases pair in a specific, consistent way.

X-ray diffraction and Bragg's law. Franklin's crystallographic method exploits the wave nature of X-rays. When a monochromatic X-ray beam of wavelength strikes a crystalline or fibrous sample, the radiation scattered from successive molecular planes interferes constructively only when the path difference equals an integer multiple of . This condition is Bragg's law:

where is the spacing between successive planes and is the angle between the incident beam and the plane. For a helical molecule the diffraction pattern has a characteristic X-shape whose geometry encodes the helix parameters directly: the layer-line spacing gives the pitch, the meridional reflection gives the rise per residue, and the overall cross confirms the helical symmetry.

The central dogma (Crick, 1958; restated 1970). Crick's dogma is a statement about the directional transfer of sequence information — the precise order of monomers in a biopolymer. The general transfers, occurring in all cells, are:

  • DNA → DNA (replication)
  • DNA → RNA (transcription)
  • RNA → protein (translation)

The special transfers, occurring only in particular systems, are RNA → RNA (RNA virus replication) and RNA → DNA (reverse transcription, discovered in retroviruses by Temin and Baltimore, 1970). The forbidden transfers — protein → protein, protein → RNA, protein → DNA — have never been observed. The dogma does not prohibit the reverse flow of regulatory or structural information; it prohibits the translation of an amino acid sequence back into a nucleotide sequence. Crick's point was that no known mechanism reads protein sequence and writes it into nucleic acid.

The genetic code. The four nucleotide bases are read in non-overlapping triplets called codons. A sequence of bases therefore specifies codons. There are codons: 61 are "sense" codons specifying the twenty standard amino acids, and three (UAA, UAG, UGA) are stop codons terminating translation. Because 64 > 20, the code is degenerate: most amino acids are specified by between two and six codons. The code is near-universal — with minor variations in mitochondria and a few microorganisms — which is strong evidence that all life shares a common ancestor (§19.07., §31.04.). Degeneracy buffers the organism against mutation: many single-base changes are "silent," producing the same amino acid and therefore no change in the protein.

Key theorem with proof Intermediate+

Key derivation (the triplet nature of the genetic code). Before any codon was experimentally decoded, the codon length was already constrained by a counting argument. The argument runs as follows.

Proof. Let the genetic alphabet contain symbols (the bases A, U/T, G, C), and let the set of targets contain amino acids plus at least one stop signal. A codon of length is an element of , so the number of distinct codons of length is . For the code to assign every amino acid at least one codon, we require

For : . For : . For : . Therefore .

This argument was made independently by George Gamow and by Crick, Leslie Barnett, Sydney Brenner, and Richard Watts-Tobin in the 1950s. Gamow proposed a specific overlapping-triplet code that turned out to be wrong, but his counting insight was correct: the code must be at least a triplet. The argument also predicts degeneracy, since exceeds the 21 needed symbols by 43, so on average each amino acid is specified by roughly codons. The 1961 experiment of Nirenberg and Matthaei — showing that synthetic poly-U RNA directs the synthesis of poly-phenylalanine — confirmed both the triplet structure (three U's per phenylalanine) and the first specific assignment (UUU → Phe). The argument is a clean example of how a combinatorial constraint can narrow a scientific question before any experiment is performed.

Key result (Bragg's law and the helical parameters of DNA). The structural measurements that Franklin extracted from Photo 51, and that Watson and Crick used to constrain their model, are all consequences of Bragg's law applied to a helical diffraction pattern. The key relations are:

For a helix of radius and axial rise per residue, the diffraction pattern consists of a series of layer lines indexed by integers, producing the characteristic "helical cross." The axial rise is read from the meridional reflection (the spot lying on the vertical axis of the pattern), which appears at a spacing corresponding to . Franklin measured this at Å, giving Å per base pair. The layer-line spacing gives the helical pitch (the axial distance for one full turn) as Å, so the number of base pairs per turn is . The overall diameter, read from the lateral extent of the pattern, is approximately Å. These three numbers — Å rise, base pairs per turn, Å diameter — were the constraints that Watson and Crick's model had to satisfy, and did. The right-handed B-form helix, with antiparallel strands and inward-facing complementary bases, is the unique chemically reasonable structure consistent with all three measurements and with Chargaff's rules. Bragg's law thus connects the abstract geometry of wave interference to the physical structure of the molecule of heredity.

Key result (semi-conservative replication, Meselson–Stahl 1958). Once the double helix was known, three replication mechanisms remained compatible with its structure: conservative (the parental helix stays intact and guides assembly of an entirely new one), semi-conservative (each parental strand pairs with a newly synthesized partner), and dispersive (parental and new DNA are interspersed in both daughter helices). Matthew Meselson and Franklin Stahl distinguished them by growing E. coli in heavy nitrogen (N), then shifting the culture to light (N) medium and tracking DNA density across generations by equilibrium centrifugation. After one round of replication all DNA settled at a single hybrid density — half heavy, half light — ruling out the conservative model (which predicts two separate bands). After two rounds, two bands appeared in equal amounts: hybrid and fully light, ruling out the dispersive model (which predicts a single band migrating toward light). Only semi-conservative replication produces exactly this pattern. The experiment is sometimes called "the most beautiful in biology."

Exercises Intermediate+

Advanced results Master

The molecular-biology revolution of 1953–2003 transformed not only biology but medicine, agriculture, computing, and ethics. Below are the principal strands that extend beyond the introductory narrative.

The Franklin controversy

Brenda Maddox's Rosalind Franklin: The Dark Lady of DNA (2002) established the authoritative account of Franklin's role. Franklin was not a passive data source: by early 1953 she had recognized the B-form helix symmetry, had measured its parameters precisely, and was preparing a manuscript presenting the structural evidence. Watson and Crick's model-building approach was faster, but it depended entirely on the quantitative constraints her crystallography provided. The data reached Cambridge through Maurice Wilkins, who showed Franklin's unpublished Photo 51 to Watson, and through an MRC report whose circulation Franklin did not control. The 1962 Nobel Prize went to Watson, Crick, and Wilkins — Franklin had died of ovarian cancer in 1958, and Nobels are not awarded posthumously.

Watson's 1968 memoir The Double Helix presented the discovery as a dramatic race and portrayed Franklin ("Rosy") as abrasive and uncooperative. Later scholarship — Anne Sayre (1975), Maddox (2002), and Matthew Cobb's Life's Greatest Secret (2015) — corrected the portrait. Watson himself expressed regret in later editions. The case is now a locus classicus for the gender dynamics of science (§30.04.04, women in science), for feminist philosophy of science (§31.02., §20.08.), and for the broader question of how credit is assigned in collaborative and competitive research environments. The history of women in chemistry and physics — Marie Curie, Lise Meitner, Chien-Shiung Wu — provides parallel cases (§33.04.*).

The molecular-biology revolution

Michel Morange's A History of Molecular Biology (1998) traces the field from classical genetics to genome engineering. The decisive institutional innovation was the "phage group" — Max Delbrück, Salvador Luria, and Alfred Hershey, who agreed in the 1940s to study bacterial viruses (bacteriophages) as the simplest self-replicating systems. Delbrück, a physicist turned biologist, imposed on the group a discipline of focusing on a single model organism and a shared set of techniques, an approach modeled on the physics community he had left. The phage group met annually at Cold Spring Harbor Laboratory on Long Island; its members called their gatherings "prayer meetings" and themselves, half-jokingly, the "Phage Church."

The Delbrück-Luria fluctuation experiment of 1943 was the group's founding result. By showing that mutations conferring viral resistance arise randomly in bacterial populations before exposure to the virus — not in response to it — Delbrück and Luria demonstrated that mutation is a stochastic process, not a directed adaptation. This was a direct application of statistical reasoning to biology and a decisive blow to Lamarckian inheritance in microorganisms (§19.04., drift and mutation; §20.08., philosophy of science). The molecular-biology revolution thus began as much with a probabilistic argument as with a structural model.

Molecular biology and physics

A striking feature of the revolution is how many of its founders were trained as physicists. Delbrück had been an assistant to Niels Bohr. Francis Crick had worked on magnetic mines during the war and came to biology from physics. Leo Szilard, the nuclear physicist, turned to molecular biology in the 1950s and made contributions to feedback regulation in gene expression (the Jacob-Monod operon). The conduit between the fields was Erwin Schrödinger's 1944 book What is Life?, which posed the question of heredity in physical terms and introduced the concept of an "aperiodic crystal" — a molecule carrying information in its precise but non-repeating structure. Schrödinger's aperiodic crystal was a direct inspiration to both Crick and Watson, and it framed the gene as an information-storage problem before the structure of DNA was known (§33.05., quantum revolution; §20.08., philosophy of science, paradigm transfer).

This migration of physicists into biology was a transfer of both methods and sensibilities. The physicist's emphasis on model-building, on identifying the simplest system that captures the essential phenomenon, and on seeking exact quantitative predictions shaped the early molecular-biology program. It also contributed to the mathematization of biology that characterizes the modern discipline — from the statistical mechanics of protein folding to the information-theoretic analysis of genomes (§33.03.*, Scientific Revolution, mathematization).

Biotechnology industry

The founding of Genentech in 1976 by Herbert Boyer (a molecular biologist) and Robert Swanson (a venture capitalist) marks the birth of the biotechnology industry. Genentech's first product was recombinant human insulin, produced by inserting the human insulin gene into E. coli and harvesting the protein — the first commercial product of genetic engineering (previously insulin was extracted from pig and cow pancreases). The company's 1980 IPO, which saw its share price double on the first day, signaled that molecular biology had become an economic force as well as a scientific one.

The industry now encompasses pharmaceuticals (§35.07., pharmacology), agricultural biotechnology (genetically modified crops), industrial enzymes, and the emerging field of synthetic biology. The commercialization raises the standard questions about the relationship between publicly funded basic research and private appropriation: many of the foundational techniques — restriction enzymes, PCR, CRISPR — were developed in academic laboratories with public funding, then commercialized under patent protection. The Myriad Genetics case (2013), in which the US Supreme Court ruled that naturally occurring DNA sequences cannot be patented, drew a boundary around the patentability of biological information that remains contested. Gene therapy and CRISPR-based therapeutics (§35.08., future medicine) extend these questions into clinical practice, and the ethics of biotechnology commercialization intersects with broader frameworks for evaluating emerging technologies (§20.02.06).

Genetics and ethics

The history of genetics is inseparable from the history of eugenics — the early-20th-century movement to "improve" the human species by controlling reproduction. Eugenics was supported by prominent geneticists (including R. A. Fisher and Herman Muller) and by political leaders across the ideological spectrum. In the United States, eugenic sterilization laws were enacted in over thirty states and resulted in the forced sterilization of more than 60,000 people, sanctioned by the Supreme Court in Buck v. Bell (1927). Nazi Germany took eugenic logic to its genocidal extreme. The movement discredited itself through its association with Nazi atrocities, but its assumptions — that complex human traits are primarily hereditary, that social problems have biological solutions — persist in attenuated forms (§19.05., quantitative genetics; §29.09., psychological disorders; §30.04.03, race and ethnicity; §20.02.*, ethics).

Contemporary bioethics confronts a different but related set of questions. Genetic testing enables prenatal screening for hundreds of conditions, raising questions about the boundary between preventing disease and selecting for "desirable" traits. The Genetic Information Nondiscrimination Act (GINA, 2008) prohibits the use of genetic information in employment and health insurance in the United States, but genetic privacy remains a live concern as consumer genomics (23andMe and similar services) makes sequencing cheap and accessible (§36., media literacy, data privacy; §31.04.03, human variation; §31.06.02, medical anthropology). The 2018 case of He Jiankui, who used CRISPR to edit the CCR5 gene in human embryos, producing the first gene-edited babies, drew near-universal condemnation and underscored the gap between technical capability and ethical readiness for human germline modification (§35.08., future medicine; §20.02.06).

Molecular biology and evolution

Molecular data transformed evolutionary biology. Emile Zuckerkandl and Linus Pauling proposed the molecular clock in 1962: the observation that amino acid substitutions in a given protein accumulate at an approximately constant rate, so the genetic distance between two species is proportional to the time since their divergence. Motoo Kimura's neutral theory of molecular evolution (1968) argued that most molecular variation is selectively neutral — a direct challenge to the selectionist consensus and one of the great debates of 20th-century biology (§19.07.02, molecular clock; §19.04.02, neutral theory). Molecular phylogenetics, using DNA and protein sequences rather than morphology to reconstruct evolutionary trees, resolved longstanding questions about relationships that morphology could not settle and is now the standard method (§19.07.*, phylogenetics).

Ancient DNA, pioneered by Svante Pääbo (2022 Nobel), opened a direct window into the genetics of extinct organisms. The sequencing of the Neanderthal genome revealed that modern humans outside Africa carry ~2% Neanderthal DNA — evidence of interbreeding that rewrote the story of human origins (§31.04.02, human evolution; §32.01.02, human dispersal; §31.04.03, human variation). Ancient DNA has also been used to trace the spread of agriculture, the movements of ancient populations, and the evolution of pathogens — a field that barely existed three decades ago and now generates headlines annually.

Molecular biology and medicine

The clinical impact of molecular biology began with Linus Pauling's 1949 characterization of sickle-cell anemia as a "molecular disease" — a disorder caused by a single amino acid substitution in hemoglobin. This was the first time a disease was explained at the molecular level, and it established the paradigm that has dominated medicine ever since: understand the molecule, understand the disease. Cancer biology has been transformed by the identification of oncogenes and tumor suppressors, enabling targeted therapies such as imatinib (Gleevec) for chronic myeloid leukemia (§35.03., cancer biology; §35.08., future medicine, personalized medicine).

Pharmacogenomics — the study of how genetic variation affects drug response — promises to replace one-size-fits-all prescribing with individually tailored therapies (§35.07., pharmacology, pharmacokinetics; §35.08., precision medicine). Gene therapy, long hampered by delivery and safety problems, was transformed by the development of CRISPR-Cas9 by Jennifer Doudna and Emmanuelle Charpentier (2020 Nobel). The first CRISPR therapy, for sickle-cell disease, was approved in 2023. Most recently, mRNA vaccine technology, developed over three decades by Katalin Karikó and Drew Weissman (2023 Nobel), enabled the rapid deployment of effective COVID-19 vaccines and is now being applied to cancer immunotherapy and other infectious diseases (§35.06., public health, vaccine science; §35.02., infectious disease, pandemic response). The arc from Pauling's hemoglobin to CRISPR and mRNA is a single line: the molecular understanding of disease leading to molecular treatment.

Connections Master

  • §33.06.01 (genetics and the molecular biology revolution). The prerequisite unit. This unit assumes Mendelian genetics, the chromosome theory, Avery's transforming principle, and the basic fact of DNA structure, all developed there. The present unit deepens the double-helix story, the central dogma, and the ethical and industrial aftermath.

  • §33.05.* (the quantum and relativity revolutions). The double helix is, at the chemical level, an applied quantum object. Covalent bonding, hydrogen bonding, and the base-pairing specificity that underlies heredity are all quantum-mechanical phenomena. The migration of physicists into biology (Delbrück, Crick, Szilard) carried quantum-era sensibilities into the life sciences, and Schrödinger's What is Life? (1944) was the explicit bridge.

  • §17.* (molecular and cell biology) and especially §17.06.* (molecular genetics). This unit is the historical account; chapter 17 is the systematic theory. DNA replication, transcription, translation, DNA repair, gene regulation, and the cell cycle receive their full mechanistic treatment there. §17.05.05 covers the ribosome and the genetic code in detail; §17.01.* treats protein structure and folding.

  • §19.01.* (Mendelian genetics) and §19.07.* (phylogenetics). Mendel's laws (§19.01) provide the conceptual foundation that the double helix mechanistically explains. The universality of the genetic code is primary evidence for common ancestry and molecular phylogenetics (§19.07.*). The molecular clock (§19.07.02) and neutral theory (§19.04.02) are direct descendants of the molecular-biology revolution.

  • §33.04.* (the chemistry revolution). X-ray crystallography, the technique that made Photo 51 possible, descends from the Braggs' work on crystal structure in the 1910s. The women of crystallography — Kathleen Lonsdale, Dorothy Hodgkin, Franklin — connect the chemistry and molecular-biology chapters.

  • §28.06.* (space telescopes) and §28.05.* (exoplanet detection). The X-ray diffraction methods Franklin used are the same physics that underlies X-ray astronomy. Conversely, the sequencing technologies developed for the Human Genome Project feed into the search for biosignatures and the analysis of returned samples.

  • §35.02.* (infectious disease) and §35.08.* (future medicine). PCR diagnostics, mRNA vaccines, CRISPR therapeutics, gene therapy, and genomic medicine are all direct applications of the molecular biology this unit describes. The COVID-19 pandemic demonstrated the maturity of these technologies: the pathogen was sequenced within weeks and vaccines deployed within months.

  • §35.07.* (pharmacology) and §35.03.* (cancer biology). Molecular targets for drugs, pharmacogenomics, oncogene-directed therapy, and the molecular classification of tumors are all clinical expressions of the central dogma's practical legacy.

  • §33.07.02 (the digital revolution). The proposed successor. Molecular biology contributed computational concepts — sequence as information, the genetic code as a literal code — that shaped the information-theoretic framing of computing, and bioinformatics (§50.*) is now a major application domain of computer science. The Human Genome Project was among the first "big data" biology projects.

  • §20.08.* (philosophy of science). The Franklin controversy, the reception of the central dogma, the Forman-style question of why physicists migrated into biology, and the sociological study of the phage group are all cases for philosophy and sociology of science. The coding problem (the key derivation above) is a clean example of a combinatorial constraint narrowing a scientific question.

  • §20.02.* (ethics), §20.02.06 (AI ethics / emerging technology ethics), and §30.04.03 (race and ethnicity). Eugenics, genetic privacy, germline editing, and the misuse of genetic data are the principal ethical burdens of the field. The history of forced sterilization (Buck v. Bell) and the persistence of genetic determinism in popular discourse connect directly to §30.04.03 and §29.09.*.

  • §33.08.* (big science). The Human Genome Project is a canonical case of late-20th-century big science — large, international, capital-intensive, and dependent on computational infrastructure. The model it established (open data release, international coordination, public-private competition with Celera) shaped subsequent large-scale biology projects.

Historical and philosophical context Master

The molecular-biology revolution can be dated to a single publication. James Watson and Francis Crick's "Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid" appeared in Nature on 25 April 1953 — a paper of roughly 900 words, one figure, and no experimental data of its own. Its famous closing sentence — "It has not escaped our notice that the specific pairing we have postulated immediately suggests a possible copying mechanism for the genetic material" — ranks among the most consequential understatements in scientific literature. The paper appeared back-to-back with two companion papers from King's College: one by Maurice Wilkins, Alexander Stokes, and Herbert Wilson, and one by Rosalind Franklin and Raymond Gosling, each presenting the X-ray diffraction evidence. The three papers together constituted the case for the double helix; Watson and Crick supplied the model, Franklin and Wilkins supplied the measurements that constrained it, and neither side could have stood alone.

Franklin's paper, "Molecular Configuration in Sodium Thymonucleate," was the most quantitatively rigorous of the three. It reported the B-form parameters — the helical pitch, the fiber-axis repeat, the unit cell dimensions — and concluded that the structure was compatible with a helical arrangement of two or three co-axial molecules. Franklin was cautious about the number of strands, and her paper did not commit to a specific model. But her data were the data Watson and Crick used, and her conclusion that the phosphate backbone lies on the exterior of the molecule was the correction that made their model chemically viable. She submitted the paper before seeing the Watson-Crick model; it was not an endorsement of their structure, but it was the independent evidence that their structure required.

Oswald Avery, Colin MacLeod, and Maclyn McCarty's 1944 paper, "Studies on the Chemical Nature of the Substance Inducing Transformation of Pneumococcal Types," had established nine years earlier that DNA is the carrier of genetic information. The paper showed that purified DNA from a virulent strain of Pneumococcus could permanently transform a non-virulent strain into a virulent one — the first demonstration that a chemical substance carries heritable traits. The result was met with widespread skepticism. Most biochemists believed proteins, with their twenty amino acids and near-infinite combinatorial variety, were the only plausible carriers of the specificity that heredity requires. DNA, with only four bases, seemed too simple. The resistance to Avery's result — sustained for nearly a decade, until Hershey and Chase's 1952 blender experiment provided independent confirmation — is a textbook case of how preconception can slow the reception of evidence, and how the "scientific change" that philosophy of science attempts to model actually unfolds in practice (§20.08.*).

Alfred Hershey and Martha Chase's 1952 experiment was the decisive confirmation. They labeled the DNA of bacteriophages with radioactive phosphorus and the protein coat with radioactive sulfur, then allowed the viruses to infect bacteria. After using a blender to strip the empty protein coats off the bacterial surfaces, they found that the radioactive phosphorus — the DNA — had entered the bacteria, while the radioactive sulfur — the protein — had not. The genetic material that directed the production of new viruses was DNA. The experiment was technically simple and conceptually decisive, and it shifted the consensus that Avery's careful biochemistry had only dented.

The central dogma entered molecular biology through a remark Crick made at a 1957 symposium and then formalized in his 1958 paper "On Protein Synthesis." The term "dogma" was, by Crick's own admission, a misnomer — he meant a hypothesis about information flow, not an article of faith — but the name stuck. Crick's 1970 restatement, published in Nature in response to the confusion caused by the discovery of reverse transcription, carefully distinguished the general transfers (DNA → DNA, DNA → RNA, RNA → protein) from the special transfers (RNA → DNA, RNA → RNA, DNA → protein) and the forbidden transfers (protein → anything). The dogma's substance is the prohibition of the reverse readout of protein sequence into nucleic acid, a prohibition that has held for half a century despite the discovery of every other class of information transfer.

The ethical shadow of the revolution fell early. The Asilomar Conference of February 1975, organized by Paul Berg and others at the Asilomar Conference Center in California, was a landmark exercise in scientific self-regulation. Recombinant DNA technology — the ability to join DNA from different organisms and propagate it in bacteria — had advanced faster than the assessment of its risks, and a voluntary moratorium on certain experiments was in effect. Asilomar produced a set of containment guidelines that allowed the research to resume under controlled conditions, and it became the model invoked whenever a new biotechnology — cloning, gene therapy, CRISPR, synthetic biology — raised analogous questions. The precedent is double-edged: Asilomar demonstrated that scientists can regulate themselves effectively, but it also placed regulation in the hands of those most invested in the research proceeding, a tension that recurs in debates over gain-of-function research and AI governance (§20.02.06).

The Human Genome Project, launched in 1990 and declared complete in 2003, was the revolution's capital project. It was proposed by Renato Dulbecco in 1986, initiated by James Watson as its first director (he resigned in 1992 over disputes about gene patenting), led to completion by Francis Collins in the public consortium, and raced competitively by Craig Venter's Celera Genomics using a whole-genome shotgun approach. The project produced a reference sequence of the approximately three billion base pairs of human DNA, identifying roughly 20,000–25,000 protein-coding genes — far fewer than the 100,000 many had predicted. The completion was announced jointly by Bill Clinton and Tony Blair in June 2000, with Clinton declaring that "today we are learning the language in which God created life." Whether or not that claim is true, the sequence has become the substrate of genomic medicine, of thousands of genome-wide association studies, and of the ongoing effort to understand how a parts list of 20,000 genes produces a human being.

Bibliography Master

Primary sources

  1. Avery, O. T., MacLeod, C. M., and McCarty, M. "Studies on the Chemical Nature of the Substance Inducing Transformation of Pneumococcal Types." Journal of Experimental Medicine 79, 1944, pp. 137-158. The demonstration that DNA carries hereditary information; met with a decade of skepticism.

  2. Hershey, A. D. and Chase, M. "Independent Functions of Viral Protein and Nucleic Acid in Growth of Bacteriophage." Journal of General Physiology 36, 1952, pp. 39-56. The blender experiment confirming that DNA, not protein, is the genetic material.

  3. Franklin, R. E. and Gosling, R. G. "Molecular Configuration in Sodium Thymonucleate." Nature 171, 1953, pp. 740-741. Franklin's own presentation of the B-form diffraction evidence, published alongside the Watson-Crick paper.

  4. Watson, J. D. and Crick, F. H. C. "Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid." Nature 171, 1953, pp. 737-738. The double helix; one figure, no own data, and the most consequential sentence in molecular biology.

  5. Wilkins, M. H. F., Stokes, A. R., and Wilson, H. R. "Molecular Structure of Deoxypentose Nucleic Acids." Nature 171, 1953, pp. 738-740. The third of the back-to-back papers; independent crystallographic evidence for the helix.

  6. Meselson, M. and Stahl, F. W. "The Replication of DNA in Escherichia coli." Proceedings of the National Academy of Sciences 44, 1958, pp. 671-682. The experiment demonstrating semi-conservative replication.

  7. Crick, F. H. C. "On Protein Synthesis." Symposium of the Society for Experimental Biology 12, 1958, pp. 138-163. The original statement of the central dogma.

  8. Nirenberg, M. W. and Matthaei, J. H. "The Dependence of Cell-Free Protein Synthesis in E. coli upon Naturally Occurring or Synthetic Polyribonucleotides." Proceedings of the National Academy of Sciences 47, 1961, pp. 1588-1602. The first codon assignment: UUU → phenylalanine.

  9. Temin, H. M. and Mizutani, S. "RNA-Dependent DNA Polymerase in Virions of Rous Sarcoma Virus." Nature 226, 1970, pp. 1211-1213. The discovery of reverse transcriptase, jointly with Baltimore's parallel paper in the same issue.

  10. Crick, F. "Central Dogma of Molecular Biology." Nature 227, 1970, pp. 561-563. The restatement accommodating reverse transcription; the canonical formulation.

  11. Saiki, R. K. et al. "Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia." Science 230, 1985, pp. 1350-1354. The first publication of the polymerase chain reaction.

  12. International Human Genome Sequencing Consortium. "Initial Sequencing and Analysis of the Human Genome." Nature 409, 2001, pp. 860-921. The draft human genome sequence; the public consortium's report.

  13. Jinek, M. et al. "A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity." Science 337, 2012, pp. 816-821. The foundational CRISPR-Cas9 paper by Doudna and Charpentier.

Secondary works

  1. Bowler, P. J. and Morus, I. R. Making Modern Science: A Historical Survey. 2nd ed. Chicago: University of Chicago Press, 2005. Chapter 8 ("Molecular biology") is the standard brief survey; the recommended beginner anchor.

  2. Morange, M. A History of Molecular Biology. Translated by Matthew Cobb. Cambridge, MA: Harvard University Press, 1998. The comprehensive scholarly history; the recommended intermediate anchor.

  3. Watson, J. D. The Double Helix: A Personal Account of the Discovery of the Structure of DNA. New York: Atheneum, 1968. The controversial firsthand narrative; the recommended master anchor. Read alongside Maddox for balance.

  4. Maddox, B. Rosalind Franklin: The Dark Lady of DNA. New York: HarperCollins, 2002. The authoritative biography; corrects Watson's portrait and establishes Franklin as a principal investigator in her own right.

  5. Judson, H. F. The Eighth Day of Creation: Makers of the Revolution in Biology. New York: Simon and Schuster, 1979. The definitive narrative history of molecular biology, from Avery to recombinant DNA.

  6. Schrödinger, E. What is Life? The Physical Aspect of the Living Cell. Cambridge: Cambridge University Press, 1944. The book that drew physicists into biology; the "aperiodic crystal" concept that inspired Crick and Watson.

  7. Cobb, M. Life's Greatest Secret: The Race to Crack the Genetic Code. New York: Basic Books, 2015. The authoritative account of the coding problem and its resolution, integrating the Franklin reassessment.

  8. Olby, R. The Path to the Double Helix. Seattle: University of Washington Press, 1974. Reprint, New York: Dover, 1994. The classic technical history of the structural problem from Miescher to Watson and Crick.